Bharat Immunologicals & Biologicals Corporation Q1 Results

  • BSE: 524663
  • NSE: -
  • ISIN: INE994B01014
  • Sector: Major Drugs
BSE
23.630.01 (0.04%)
Volume31.58 K
Updated: Mon 25 Nov, 2024 | 15:49:10
NSE
This stock is not traded on NSE
Today: 23.26
24.20
52-Wk: 22.25
43.89

Q1 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Bharat Immunologicals & Biologicals Corporation Q1 Results

    *All figures in crores except per share values
    Fiscal PeriodJun 23Mar 23QoQ Comp
    Total Revenue 0.007.65-%
    Depreciation/ Amortization 0.030.04-%
    Other Operating Expenses Total 0.422.90-%
    Total Operating Expense 4.3514.10-%
    Operating Income -4.35-6.45-%
    Net Income Before Taxes -5.97-6.26-%
    Net Income -4.59-4.29-%
    Diluted Normalized EPS -1.06-0.99-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts